Evidence map›Paper›PMID 31908792›Full record

ArticleBMJ open diabetes research & care2019

Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis.

Heather Stuckey, Lawrence Fisher, William H Polonsky, Danielle Hessler, Frank J Snoek, Tricia S Tang, Norbert Hermanns, Xavier Mundet-Tuduri, Maria Elizabeth Rossi da Silva, Jackie Sturt and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia-Pacific Region.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 8 countries.

Heather StuckeyPennsylvania State University, Hershey, Pennsylvania, USA.
Lawrence FisherUniversity of California San Francisco, San Francisco, California, USA.
William H PolonskyBehavioral Diabetes Institute, University of California, San Diego, Del Mar, California, USA.
Danielle HesslerUniversity of California San Francisco, San Francisco, California, USA.
Frank J SnoekAmsterdam University Medical Centre Vrije Universiteit, Amsterdam, The Netherlands.
Tricia S TangUniversity of British Columbia, Vancouver, British Columbia, Canada.
Norbert HermannsDiabet Acad Mergentheim FIDAM, Bad Mergentheim, Germany.
Xavier Mundet-TuduriUniversitat Autonoma de Barcelona, Bellaterra, Spain.
Maria Elizabeth Rossi da SilvaHospital das Clínicas da Faculdade de Medicina da USP, Sao Paulo, Brazil.
Jackie SturtKing's College London, London, UK.
Kentaro OkazakiNagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-8449-804X
Dachuang CaoEli Lilly and Company, Indianapolis, Indiana, USA.
Irene HadjiyianniLilly Deutschland GmbH, Bad Homburg, Germany.
Jasmina I IvanovaAnalysis Group Inc Boston, Boston, Massachusetts, USA.
Urvi DesaiAnalysis Group Inc Boston, Boston, Massachusetts, USA.ORCID 0000-0001-5196-7201
Magaly Perez-NievesEli Lilly and Company, Indianapolis, Indiana, USA.
Analysis Group (United States) · USEli Lilly (United States) · USUniversity of California, San Francisco · USEli Lilly (Germany) · DEGerman Diabetes Center Mergentheim · DEHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRKing's College London · GBNagoya University · JPPennsylvania State University · USUniversitat Autònoma de Barcelona · ESUniversity of British Columbia · CAUniversity of California San Diego · USVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To understand participant perceptions about insulin and identify key behaviors of healthcare professionals (HCPs) that motivated initially reluctant adults from seven countries (n=40) who had type 2 diabetes (T2D) to start insulin treatment. Research design and methods: Telephone interviews were conducted with a subset of participants from an international investigation of adults with T2D who were reluctant to start insulin (EMOTION). Questions related to: (a) participants' thoughts about insulin before and after initiation; (b) reasons behind responses on the survey that were either 'not helpful at all' or 'helped a lot'; (c) actions their HCP may have taken to help start insulin treatment; and (d) advice they would give to others in a similar situation of starting insulin. Responses were coded by two independent reviewers (kappa 0.992). Results: Starting insulin treatment was perceived as a negative experience that would be painful and would lead down a 'slippery slope' to complications. HCPs engaged in four primary behaviors that helped with insulin acceptance: (1) showed the insulin pen/needle and demonstrated the injection process; (2) explained how insulin could help with diabetes control and reduce risk of complications; (3) used collaborative communication style; and (4) offered support and willingness to answer questions so that participants would not be 'on their own'. Following initiation, most participants noted that insulin was not 'as bad as they thought' and recommended insulin to other adults with T2D. Conclusions: Based on these themes, two actionable strategies are suggested for HCPs to help people with psychological insulin resistance: (1) demonstrate the injection process and discuss negative perceptions of insulin as well as potential benefits; (2) offer autonomy in a person-centred collaborative approach, but provide support and accessibility to address concerns. These findings help HCPs to better understand ways in which they can engage reluctant people with T2D with specific strategies.

Indexed as

Patient Acceptance of Health CareTreatment RefusalAdultAgedCommunicationDiabetes Mellitus, Type 2FearFemaleHealth PersonnelHumansInjectionsInsulinInterviews as TopicMaleMiddle AgedNeedlesInsulinpatient-provider relationshippsychological insulin resistancetype 2 diabetes

Identifiers

PMID31908792
PMCPMC6936574
OpenAlexW2995809744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.